Healthcare Market Research Reports

The global Healthcare industry is undergoing an era of significant change. The expansion of telemedicine, progress in personalized medicine, and the adoption of advanced diagnostic technologies are rapidly reshaping the market. To remain competitive and capitalize on emerging opportunities, businesses need access to the latest market research and insights.

Frost & Sullivan provides comprehensive market research reports for the Healthcare sector, featuring detailed market forecasts, industry trend analyses, competitive benchmarks, and future growth opportunity assessments. Our reports are crafted by leading industry analysts and researchers, utilizing a thorough research methodology that combines primary and secondary data sources....

Key Topics Covered in Healthcare:

Drug Development & Innovation:

  • Rare Disease Treatment Market (Orphan Drugs): Analyzes orphan drugs for rare diseases, including development, regulations, and commercialization.
  • Drug Discovery Outsourcing Trends: Explores the growing role of outsourcing in drug discovery and early-phase clinical trials.
  • Biotechnology Investment & Funding: Examines trends and opportunities for investment in the biotech sector.
  • Innovations in Small Molecule Drug Delivery: Explores advancements in delivering medications to the body more effectively.

Digital Health & Telehealth:

  • Digital Mental Health Solutions: Analyzes digital tools used to manage mental health and behavioral conditions.
  • Home Care Technology Trends: Explores the use of technology to improve home-based healthcare.
  • Mobile Medical Imaging: Analyzes the increasing use of mobile devices for medical imaging.
  • Digital Health Regulations: Analyzes regulations impacting the development and use of digital health solutions.
  • Healthcare Cloud Services: Examines the adoption of cloud-based IT solutions for healthcare organizations.

Medical Devices & Diagnostics:

  • Non-invasive Prenatal Testing: Analyzes the market for prenatal tests that are minimally invasive for the mother.
  • Cardiology Medical Imaging Informatics: Explores technologies that manage and analyze heart-specific medical imaging data.
  • Hospital-at-Home Platforms & Services: Analyzes services allowing patients to receive hospital-level care at home.
  • Digital Pathology Technology Innovations: Explores advancements in using digital tools for analyzing tissue samples.
  • Emerging Respiratory Care Companies: Identifies promising companies in the respiratory care space.
  • Sports Medicine Industry: Analyzes the market for products and services used in sports medicine.
  • Cardiovascular Devices: Analyzes the market for devices used to treat heart conditions.
  • Diabetes Care Devices: Analyzes the market for devices used to manage diabetes.
  • Molecular Diagnostics for Neurodegenerative Diseases: Analyzes the development and potential of diagnostics for diseases like Alzheimer's and Parkinson's.
  • Smartphone-based Point-of-care Testing: Analyzes advancements in using smartphones for medical testing at the point of care.
  • Diagnostics Lab Automation & Monitoring Solutions: Explores the market for automated solutions used in diagnostic laboratories.

Other Healthcare Growth Areas:

  • Oral Solid Dosage Formulation Industry: Explores opportunities in developing and manufacturing oral medications.
  • Direct-to-Consumer Wellness Testing: Examines the growing market for genetic and other wellness tests available directly to consumers.

Clinical Trials & Drug Development Services:

  • Growth Opportunities in Drug Discovery and Early Development Outsourcing Services: Analyzes the trend of pharmaceutical companies outsourcing drug discovery and early development activities.
  • Innovative AI-enabled Clinical Trial Companies: Identifies and analyzes promising companies using AI in clinical trials.

Biopharmaceutical Products:

  • Growth Opportunities in Global Diabetes and Obesity Therapeutics: Analyzes the market for drugs used to treat diabetes and obesity.
  • Advances and Growth Opportunities in Ophthalmology Therapeutics (Biologics): Explores advancements and market opportunities for biologic drugs used in treating eye diseases.

For further information on Frost & Sullivan’s research or to speak to one of our team of growth experts about your company’s future growth needs please contact us.

  1. 13 Oct 2022  |  Global  |  Technology Research

    Technological Innovations and Growth Opportunities in Diagnostic Biochips

    Rapidly Evolving Microfluidic Biochips Enable Low-cost Point-of-care Diagnostics

    Biological systems are complex and involve several biological reactions and biomolecules. Understanding the biological reactions and identifying the associated biomolecules will help in the development of accurate diagnostics and aid precision medicine. Yet the high number of molecules often requires multiple tests or bulky instruments. To overcome...

    $4,950.00
  2. 28 Sep 2022  |  Global  |  Technology Research

    Healthcare Mobility Solutions Growth Opportunities

    Artificial Intelligence, the Internet of Things, and Blockchain Technology Improve Hospital Communications and Patient Data Security

    Healthcare mobility relates to the use of mobile technologies, such as mobile devices and mHealth, to enhance patient care in hospitals or healthcare facilities by optimizing the workforce and improving communication, data management, and health monitoring. Healthcare mobility solutions have several advantages, including enhancing communication amo...

    $4,950.00
  3. 05 Sep 2022  |  Global  |  Technology Research

    Technology Growth Opportunities for Exosome-Mediated Drug Delivery

    Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

    Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

    $4,950.00
  4. 29 Aug 2022  |  Global  |  Technology Research

    Advancements in miRNA: Technology Assessment

    Developments in miRNA sequencing and analysis are driving future growth potential in therapeutics and diagnostics

    Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has ...

    $4,950.00
  5. 17 Aug 2022  |  Global  |  Technology Research

    Therapeutic Advances in Amyloidosis

    Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

    Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...

    $4,950.00
  6. 10 Aug 2022  |  Global  |  Technology Research

    Home Healthcare Technology Innovations and Growth Opportunities

    Bringing Critical Care Delivery to Patients’ Homes through Portable, Safe, and Easy-to-Use Ventilators, Electrocardiograms, and Dialysis and Infusion Devices

    Hospitals have been the mainstay of providing care delivery to patients, including diagnostic services and therapeutic interventions. However, as a limited number of health professionals cater to multiple patients, caregivers are unable to dedicate sufficient time to each patient to understand their needs and effectively monitor their response to t...

    $4,950.00
  7. 21 Jul 2022  |  Global  |  Technology Research

    Predictive Genetic Testing: Technology Landscape ​

    The Improved Accuracy and Clinical Utility of PGTs Will Enable the Seamless Adoption of Precision Medicine.​

    Predictive genetic testing refers to the testing of genetic mutations and variations in an individual to predict the risk of disease susceptibility and the inheritance of Mendelian diseases and other complex diseases. Genomic analysis studies such as genome-wide association studies (GWAS), SNP arrays, and the WGS of select populations have helped t...

    $4,950.00
  8. 13 Jul 2022  |  Global  |  Technology Research

    Growth Opportunities for Digital Biomarkers in Drug Development

    Transformational Growth for Clinical Trials via Enhancements to Patient Recruitment, Stratification, Monitoring, and Drug Response Comprehension

    Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data on the effectiveness of the investigation of medical products contribute to their low success rate. Digital bio...

    $4,950.00
  9. 23 Jun 2022  |  Global  |  Technology Research

    Micro- and Nanofluidic Technology Innovations for Infectious Disease Control and Management

    Advanced microfluidics-based nucleic acid testing and immunoassay platforms are enabling multiplexed detection with rapid turnaround

    The rise in both global population and travel is contributing to the increase in spread of infectious diseases. Rapid and accurate identification of the infectious pathogens are imperative for timely intervention, better patient outcomes, and control and management of the spread of the infection. Conventional infectious disease diagnoses are perfor...

    $4,950.00
  10. 22 Jun 2022  |  Global  |  Technology Research

    Growth Opportunities in AI for Drug Target Discovery and Validation

    Advancements in Deep Learning will Enable Faster and More Efficient Novel Target Discovery.

    A major challenge in drug discovery is the limited number of gene targets that can be targeted for the development of a drug molecule. Only close to 400 genes are proven targets for US FDA-approved drugs. 80% of human genes are unexplored as targets, and some are considered undruggable. The identification and the selection of novel drug targets (p...

    $4,950.00